PARION SCIENCES, INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for PARION SCIENCES, INC..The latest application filed is for "3,5-diamino-6-chloro-n-(n-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amin- o)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide".

Company Profile

26.111.140

PARION SCIENCES, INC. - Durham NC
PARION SCIENCES, INC. -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Monothiol mucolytic agents Grant 10,968,233 - Johnson , et al. April 6, 2	2021-04-06
3,5-diamino-6-chloro-n-(n-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amin- O)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide App 20210024471 - Johnson; Michael R.	2021-01-28
3,5-diamino-6-chloro-N--(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)ami- no)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide Grant 10,752,597 - Johnson A	2020-08-25
Aerosol Delivery Systems, Compositions And Methods App 20200054558 - BOUCHER; Paul ; et al.	2020-02-20
Prodrugs of dithiol mucolytic agents Grant 10,526,283 - Johnson , et al. J	2020-01-07
Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases Grant 10,526,292 - Johnson , et al. J	2020-01-07
3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) Pyrazine-2- Carboxamide Compounds App 20190308943 - Johnson; Michael R.	2019-10-10
Sodium Channel Blockers App 20190241528 - Johnson; Michael R.	2019-08-08
Methods of treatment Grant 10,335,558 - Boucher , et al.	2019-07-02
3,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide compounds Grant 10,246,425 - Johnson	2019-04-02
Chloro-pyrazine Carboxamide Derivatives With Epithelial Sodium Channel Blocking Activity App 20190084943 - Johnson; Michael R.	2019-03-21
Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds Grant 10,233,158 - Johnson	2019-03-19
Novel Monothiol Mucolytic Agents App 20190031679 - JOHNSON; Michael Ross ; et al.	2019-01-31
Arylalkyl-and Aryloxyalkyl-substituted Epithelial Sodium Channel Blocking Compounds App 20190010132 - Johnson; Michael R.	2019-01-10
Sodium channel blockers Grant 10,167,266 - Johnson J	2019-01-01
Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity Grant 10,159,672 - Johnson Dec	2018-12-25
Monothiol mucolytic agents Grant 10,106,551 - Johnson , et al. October 23, 2	2018-10-23
Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity Grant 10,071,970 - Johnson September 11, 2	2018-09-11
Inhaled hypertonic saline delivered by a heated nasal cannula Grant 9,987,443 - Boucher , et al. June 5, 2	2018-06-05
Dithiol mucolytic agents Grant 9,963,427 - Johnson , et al. May 8, 2	2018-05-08
Arylalkyl-and aryloxyalkyl-substituted epithelial sodium channel blocking compounds Grant 9,957,238 - Johnson May 1, 2	2018-05-01
Dendrimer Like Amino Amides Possessing Sodium Channel Blocker Activity For The Treatment Of Dry Eye And Other Mucosal Diseases App 20180111907 - Johnson; Michael Ross ; et al.	2018-04-26
Chemically And Metabolically Stable Dipeptide Possessing Potent Sodium Channel Blocker Activity App 20180104241 - JOHNSON; Michael	2018-04-19
Sodium Channel Blockers For Skin Disorders App 20180092915 - Johnson; Michael Ross ; et al.	2018-04-05
Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases Grant 9,878,988 - Johnson , et al. January 30, 2	2018-01-30
Stable sodium channel blockers Grant 9,856,224 - Johnson January 2, 2	2018-01-02
Sodium channel blockers for skin disorders Grant 9,849,129 - Johnson , et al. December 26, 2	2017-12-26
3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) Pyrazine-2- Carboxamide Compounds App 20170362187 - Johnson; Michael R.	2017-12-21
3,5-diamino-6-chloro-n-(n-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amin- O)ethoxy)phenyl)butyl) Carbamimidoyl)pyrazine-2-carboxamide App 20170334864 - Johnson; Michael R.	2017-11-23
Chloro-pyrazine Carboxamide Derivatives With Epithelial Sodium Channel Blocking Activity App 20170327472 - Johnson; Michael R.	2017-11-16
Arylalkyl-and Aryloxyalkyl-substituted Epithelial Sodium Channel Blocking Compounds App 20170305868 - Johnson; Michael R.	2017-10-26
Chemically And Metabolically Stable Dipeptide Possessing Potent Sodium Channel Blocker Activity App 20170281620 - JOHNSON; Michael Ross	2017-10-05
Stable Sodium Channel Blockers App 20170267649 - JOHNSON; Michael R.	2017-09-21
Sodium Channel Blockers App 20170267650 - Johnson; Michael R.	2017-09-21
3,5-diamino-6-chloro-N-(n-(4-phenylbutyl)carbamimidoyl)pyrazine-2-carboxam- ide compounds Grant 9,695,134 - Johnson July 4, 2	2017-07-04
Inhaled Hypertonic Saline Delivered By A Heated Nasal Cannula App 20170151396 - BOUCHER; Richard C. ; et al.	2017-06-01
Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity Grant 9,655,896 - Johnson May 23, 2	2017-05-23
Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity Grant 9,593,084 - Johnson March 14, 2	2017-03-14
3,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amin- o)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide Grant 9,586,910 - Johnson March 7, 2	2017-03-07
Arylalkyl- and aryloxyalkyl-substituted epthelial sodium channel blocking compounds Grant 9,586,911 - Johnson March 7, 2	2017-03-07
Sodium Channel Blockers For Skin Disorders App 20170020870 - Johnson; Michael Ross ; et al.	2017-01-26
Novel Prodrugs Of Dithiol Mucolytic Agents App 20160318861 - JOHNSON; Michael Ross ; et al.	2016-11-03
Inhaled hypertonic saline delivered by a heated nasal cannula Grant 9,408,988 - Boucher , et al. August 9, 2	2016-08-09
Novel Monothiol Mucolytic Agents App 20160222023 - JOHNSON; Michael Ross ; et al.	2016-08-04
Dithiol Mucolytic Agents App 20160194278 - JOHNSON; Michael R. ; et al.	2016-07-07
Dithiol mucolytic agents Grant 9,346,753 - Johnson , et al. May 24, 2	2016-05-24
Dendrimer Like Amino Amides Possessing Sodium Channel Blocker Activity For The Treatment Of Dry Eye And Other Mucosal Diseases App 20160122306 - JOHNSON; Michael Ross ; et al.	2016-05-05
Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases Grant 9,260,398 - Johnson , et al. February 16, 2	2016-02-16
Stable Sodium Channel Blockers App 20150376145 - JOHNSON; Michael R.	2015-12-31
Sodium Channel Blockers App 20150376146 - JOHNSON; Michael Ross	2015-12-31
Novel Mucolytic Agents App 20150307530 - JOHNSON; Michael R. ; et al.	2015-10-29
3,5-diamino-6-chloro-n-(4-phenylbutyl)carbamimidoyl) Pyrazine-2-carboxamide Compounds App 20150299142 - Johnson; Michael R.	2015-10-22
Chemically And Metabolically Stable Dipeptide Possessing Potent Sodium Channel Blocker Activity App 20150290189 - JOHNSON; Michael Ross	2015-10-15
Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds Grant 9,102,633 - Johnson August 11, 2	2015-08-11
Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity Grant 9,072,738 - Johnson July 7, 2	2015-07-07
Arylalkyl- And Aryloxyalkyl-substituted Epthelial Sodium Channel Blocking Compounds App 20150166488 - JOHNSON; Michael R.	2015-06-18
Arylalkyl- And Aryloxyalkyl-substituted Epithelial Sodium Channel Blocking Compounds App 20150166487 - Johnson; Michael R.	2015-06-18
Aerosol Delivery Systems, Compositions And Methods App 20150150803 - BOUCHER; Paul ; et al.	2015-06-04
3,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide compounds Grant 9,029,382 - Johnson May 12, 2	2015-05-12
Methods Of Treatment App 20150101597 - BOUCHER; Richard C. ; et al.	2015-04-16
Dendrimer Like Amino Amides Possessing Sodium Channel Blocker Activity For The Treatment Of Dry Eye And Other Mucosal Diseases App 20150099764 - JOHNSON; Michael Ross ; et al.	2015-04-09
Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases Grant 8,980,898 - Johnson , et al. March 17, 2	2015-03-17
Dithiol Mucolytic Agents App 20150056305 - Johnson; Michael R. ; et al.	2015-02-26
Aerosol delivery systems, compositions and methods Grant 8,945,605 - Boucher , et al. February 3, 2	2015-02-03
Sodium channel blockers Grant 8,846,688 - Johnson September 30, 2	2014-09-30
Methods of treatment Grant 8,778,383 - Boucher , et al. July 15, 2	2014-07-15
Sodium Channel Blockers App 20140179625 - Johnson; Michael R.	2014-06-26
3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) Pyrazine-2- Carboxamide Compounds App 20140170244 - Johnson; Michael R.	2014-06-19
Chloro-pyrazine Carboxamide Derivatives With Epithelial Sodium Channel Blocking Activity App 20140171447 - Johnson; Michael R.	2014-06-19
Nasal Cannula For Delivery Of Aerosolized Medicaments App 20140158127 - BOUCHER; Paul ; et al.	2014-06-12
Chemically And Metabolically Stable Dipeptide Possessing Potent Sodium Channel Blocker Activity App 20140142118 - Johnson; Michael Ross	2014-05-22
Aerosol Delivery Systems, Compositions And Methods App 20140109899 - Boucher; Paul ; et al.	2014-04-24
3,5-diamino-6-chloro-n-(n-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amin- O)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide App 20140107133 - Johnson; Michael R.	2014-04-17
Inhaled Hypertonic Saline Delivered By A Heated Nasal Cannula App 20140096765 - BOUCHER; Richard C. ; et al.	2014-04-10
3,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amin- o)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide Grant 8,669,262 - Johnson March 11, 2	2014-03-11
Poly Aromatic Sodium Channel Blockers App 20140031371 - JOHNSON; Michael Ross	2014-01-30
Dendrimer Like Amino Amides Possessing Sodium Channel Blocker Activity For The Treatment Of Dry Eye And Other Mucosal Diseases App 20130324559 - JOHNSON; Michael Ross ; et al.	2013-12-05
Heteroaromatic pyrazinoylguanidine sodium channel blockers Grant 8,575,176 - Johnson November 5, 2	2013-11-05
Inhaled hypertonic saline delivered by a heated nasal cannula Grant 8,551,534 - Boucher , et al. October 8, 2	2013-10-08
Capped pyrazinoylguanidine sodium channel blockers Grant 8,507,497 - Johnson , et al. August 13, 2	2013-08-13
3,5-diamino-6-chloro-n-(n-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amin- O)ethoxy)phenyl)butyl) Carbamimidoyl)pyrazine-2-carboxamide App 20130178482 - JOHNSON; MICHAEL R.	2013-07-11
Capped pyrazinoylguanidine sodium channel blockers Grant 8,431,579 - Johnson , et al. April 30, 2	2013-04-30
Sodium Channel Blockers App 20130012692 - JOHNSON; MICHAEL R.	2013-01-10
Aliphatic pyrazinoylguanidine sodium channel blockers with beta agonist activity Grant 8,324,218 - Johnson December 4, 2	2012-12-04
Methods of reducing risk of infection from pathogens Grant 8,314,105 - Johnson November 20, 2	2012-11-20
Pyrazinoylguanidine compounds for use as taste modulators Grant 8,288,391 - Johnson , et al. October 16, 2	2012-10-16
New Capped Pyrazinoylguanidine Sodium Channel Blockers App 20120220606 - JOHNSON; Michael R. ; et al.	2012-08-30
Sodium channel blockers Grant 8,227,474 - Johnson July 24, 2	2012-07-24
Capped pyrazinoylguanidine sodium channel blockers Grant 8,211,895 - Johnson , et al. July 3, 2	2012-07-03
Methods of Reducing Risk of Infection from Pathogens App 20120165342 - JOHNSON; Michael R. ; et al.	2012-06-28
Sodium channel blockers Grant 8,198,286 - Johnson June 12, 2	2012-06-12
Heteroaromatic Pyrazinoylguanidine Sodium Channel Blockers App 20120116083 - JOHNSON; Michael Ross	2012-05-10
Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity Grant 8,163,758 - Johnson , et al. April 24, 2	2012-04-24
Cyclic amide and ester pyrazinoylguanidine sodium channel blockers Grant 8,143,256 - Johnson March 27, 2	2012-03-27
Poly aromatic pyrazinoylguanidine sodium channel blockers Grant 8,124,607 - Johnson February 28, 2	2012-02-28
Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes Grant 8,058,278 - Johnson , et al. November 15, 2	2011-11-15
Soluble amide and ester pyrazinoylguanidine sodium channel blockers Grant 8,022,210 - Johnson September 20, 2	2011-09-20
Soluble amide and ester pyrazinoylguanidine sodium channel blockers Grant 8,008,494 - Johnson August 30, 2	2011-08-30
Cyclic Substituted Pyrazinoylguanidine Sodium Channel Blockers Possessing Beta Agonist Activity App 20110195973 - Johnson; Michael Ross	2011-08-11
Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes Grant 7,981,898 - Johnson , et al. July 19, 2	2011-07-19
Methods Of Reducing Risk Of Infection From Pathogens App 20110144338 - JOHNSON; Michael R. ; et al.	2011-06-16
Aliphatic amide and ester pyrazinoylguanidine sodium channel blockers Grant 7,956,059 - Johnson June 7, 2	2011-06-07
Capped Pyrazinoylguanidine Sodium Channel Blockers App 20110046158 - JOHNSON; Michael R. ; et al.	2011-02-24
Hetero substituted sodium channel blockers Grant 7,875,619 - Johnson January 25, 2	2011-01-25
Phenyl Substituted Pyrazinoylguanidine Sodium Channel Blockers Possessing Beta Agonist Activity App 20110008268 - Johnson; Michael Ross ; et al.	2011-01-13
Capped pyrazinoylguanidine sodium channel blockers Grant 7,868,010 - Johnson , et al. January 11, 2	2011-01-11
NEW CAPPED Pyrazinoylguanidine SODIUM CHANNEL BLOCKERS App 20110003832 - JOHNSON; Michael R. ; et al.	2011-01-06
Soluble amide and ester pyrazinoylguanidine sodium channel blockers Grant 7,842,697 - Johnson November 30, 2	2010-11-30
Sodium channel blockers Grant 7,820,678 - Johnson October 26, 2	2010-10-26
Aliphatic Pyrazinoylguanidine Sodium Channel Blockers With Beta Agonist Activity App 20100267746 - Johnson; Michael Ross	2010-10-21
Capped pyrazinoylguanidine sodium channel blockers Grant 7,807,834 - Johnson , et al. October 5, 2	2010-10-05
Methods of reducing risk of infection from pathogens Grant 7,745,442 - Johnson , et al. June 29, 2	2010-06-29
Sodium Channel Blockers App 20100144661 - Johnson; Michael R.	2010-06-10
Multiple Nebulizer Systems App 20100074881 - BOUCHER; Richard C. ; et al.	2010-03-25
Soluble Amide & Ester Pyrazinoylguanidine Sodium Channel Blockers App 20090324724 - Johnson; Michael R.	2009-12-31
Sodium Channel Blockers App 20090227530 - JOHNSON; Michael R.	2009-09-10
Poly Aromatic Sodium Channel Blockers App 20090214444 - Johnson; Michael Ross	2009-08-27
Inhaled Hypertonic Saline Delivered By A Heated Nasal Cannula App 20090104272 - BOUCHER; Richard C. ; et al.	2009-04-23
Methods Of Enhancing Mucosal Hydration And Mucosal Clearance By Treatment With Sodium Channel Blockers And Osmolytes App 20090082287 - Johnson; Michael Ross ; et al.	2009-03-26
Soluble Amide & Ester Pyrazinoylguanidine Sodium Channel Blockers App 20090076273 - JOHNSON; Michael R.	2009-03-19
Methods Of Using Sodium Channel Blockers App 20090062308 - JOHNSON; Michael R.	2009-03-05
Capped Pyrazinoylguanidine Sodium Channel Blockers App 20090018144 - Johnson; Michael R. ; et al.	2009-01-15
Method Of Treating Acid-sensing Ion Channel Mediated Pain, Cough Suppression, And Central Nervous System Disorders App 20080293740 - JOHNSON; Michael R. ; et al.	2008-11-27
Pyrazinoylguanidine Compounds For Use As Taste Modulators App 20080249109 - JOHNSON; Michael R. ; et al.	2008-10-09
Alaphatic Pyrazinoylguanidine Sodium Channel Blockers App 20080200476 - JOHNSON; Michael R.	2008-08-21
Capped pyrazinoylguanidine sodium channel blockers Grant 7,410,968 - Johnson , et al. August 12, 2	2008-08-12
Soluble Amide & Ester Pyrazinoylguanidine Sodium Channel Blockers App 20080177072 - Johnson; Michael R.	2008-07-24
Capped Pyrazinoylguanidine Sodium Channel Blockers App 20080176863 - JOHNSON; Michael R. ; et al.	2008-07-24
Soluble Amide & Ester Pyrazinoylguanidine Sodium Channel Blockers App 20080171879 - JOHNSON; Michael R.	2008-07-17
Capped Pyrazinoylguanidine Sodium Channel Blockers App 20080171880 - JOHNSON; Michael R. ; et al.	2008-07-17
Soluble amide & ester pyrazinoylguanidine sodium channel blockers Grant 7,399,766 - Johnson July 15, 2	2008-07-15
Capped Pyrazinoylguanidine Sodium Channel Blockers App 20080167466 - JOHNSON; Michael R. ; et al.	2008-07-10
Capped pyrazinoylguanidine sodium channel blockers Grant 7,388,013 - Johnson , et al. June 17, 2	2008-06-17
Alaphatic pyrazinoylguanidine sodium channel blockers Grant 7,375,107 - Johnson May 20, 2	2008-05-20
Capped pyrazinoylguanidine sodium channel blockers Grant 7,368,447 - Johnson , et al. May 6, 2	2008-05-06
Capped pyrazinoylguanidine sodium channel blockers Grant 7,368,451 - Johnson , et al. May 6, 2	2008-05-06
Sodium channel blockers Grant 7,368,450 - Johnson May 6, 2	2008-05-06
Cyclic Pyrazinoylguanidine Sodium Channel Blockers App 20080103148 - JOHNSON; Michael R.	2008-05-01
Cyclic Amide & Ester Pyrazinoylganidine Sodium Channel Blockers App 20080096896 - Johnson; Michael R.	2008-04-24
Methods Of Enhancing Mucosal Hydration And Mucosal Clearance By Treatment With Sodium Channel Blockers And Osmolytes App 20080090841 - Johnson; Michael Ross ; et al.	2008-04-17
Sodium Channel Blockers App 20080076782 - JOHNSON; Michael R.	2008-03-27
Sodium channel blockers Grant 7,345,044 - Johnson March 18, 2	2008-03-18
Methods of using sodium channel blockers Grant 7,332,496 - Johnson February 19, 2	2008-02-19
Cyclic pyrazinoylguanidine sodium channel blockers Grant 7,317,013 - Johnson January 8, 2	2008-01-08
Methods Of Using Sodium Channel Blockers App 20070265280 - Johnson; Michael R.	2007-11-15
Phenolic guanidine sodium channel blockers Grant 7,247,636 - Johnson July 24, 2	2007-07-24
Capped pyrazinoylguanidine sodium channel blockers Grant 7,247,637 - Johnson , et al. July 24, 2	2007-07-24
Methods of using phenolic guanidine sodium channel blockers Grant 7,241,766 - Johnson July 10, 2	2007-07-10
Sodium channel blockers Grant 7,192,959 - Johnson March 20, 2	2007-03-20
Sodium channel blockers Grant 7,192,960 - Johnson March 20, 2	2007-03-20
Sodium channel blockers Grant 7,192,958 - Johnson March 20, 2	2007-03-20
Sodium channel blockers Grant 7,189,719 - Johnson March 13, 2	2007-03-13
Sodium channel blockers Grant 7,186,833 - Johnson March 6, 2	2007-03-06
New capped pyrazinoylguanidine sodium channel blockers App 20070032509 - Johnson; Michael R. ; et al.	2007-02-08
Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers App 20070021439 - Johnson; Michael R.	2007-01-25
Capped pyrazinoylguanidine sodium channel blockers App 20060205738 - Johnson; Michael R. ; et al.	2006-09-14
Hetero substitued sodium channel blockers App 20060142581 - Johnson; Michael R.	2006-06-29
Capped pyrazinoylguanidine sodium channel blockers Grant 7,064,129 - Johnson , et al. June 20, 2	2006-06-20
Sodium channel blockers Grant 7,030,117 - Johnson April 18, 2	2006-04-18
Sodium channel blockers Grant 7,026,325 - Johnson April 11, 2	2006-04-11
Capped pyrazinoylguanidine sodium channel blockers App 20060052394 - Johnson; Michael R. ; et al.	2006-03-09
Capped pyrazinoylguanidine sodium channel blockers App 20060052395 - Johnson; Michael R. ; et al.	2006-03-09
Soluble amide & ester pyrazinoylguanidine sodium channel blockers App 20060040954 - Johnson; Michael R.	2006-02-23
Sodium channel blockers Grant 6,995,160 - Johnson February 7, 2	2006-02-07
Capped pyrazinoylguanidine sodium channel blockers App 20050228182 - Johnson, Michael R. ; et al.	2005-10-13
Sodium channel blockers Grant 6,903,105 - Johnson June 7, 2	2005-06-07
Sodium channel blockers App 20050113390 - Johnson, Michael R.	2005-05-26
Sodium channel blockers App 20050113389 - Johnson, Michael R.	2005-05-26
Sodium channel blockers App 20050113388 - Johnson, Michael R.	2005-05-26
Alaphatic pyrazinoylguanidine sodium channel blockers App 20050080092 - Johnson, Michael R.	2005-04-14
Capped pyrazinoylguanidine sodium channel blockers App 20050080091 - Johnson, Michael R. ; et al.	2005-04-14
Cyclic pyrazinoylguanidine sodium channel blockers App 20050059676 - Johnson, Michael R.	2005-03-17
Phenyl guanidine sodium channel blockers Grant 6,858,615 - Johnson February 22, 2	2005-02-22
Phenolic guanidine sodium channel blockers Grant 6,858,614 - Johnson February 22, 2	2005-02-22
Sodium channel blockers App 20040229884 - Johnson, Michael R.	2004-11-18
Phenolic guanidine sodium channel blockers App 20040204424 - Johnson, Michael R.	2004-10-14
Sodium channel blockers App 20040204425 - Johnson, Michael R.	2004-10-14
Sodium channel blockers App 20040198745 - Johnson, Michael R.	2004-10-07
Sodium channel blockers App 20040198747 - Johnson, Michael R.	2004-10-07
Sodium channel blockers App 20040198748 - Johnson, Michael R.	2004-10-07
Sodium channel blockers App 20040198746 - Johnson, Michael R.	2004-10-07
Methods of using phenolic guanidine sodium channel blockers App 20040198744 - Johnson, Michael R.	2004-10-07
Methods of using sodium channel blockers App 20040198749 - Johnson, Michael R.	2004-10-07
Sodium channel blockers App 20040162296 - Johnson, Michael R.	2004-08-19

Company Registrations

NCAGE Code	50KB0	PARION SCIENCES, INC.
CAGE Code	50KB0	PARION SCIENCES, INC.
S.A.M. Registration	50KB0 [96851774]	PARION SCIENCES, INC.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.